XML 25 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Jun. 30, 2014
Jun. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:                  
Net (loss) income $ (9,967) $ 1,764 $ (6,736) $ 12,961 $ (15,537) $ 28,479 $ (18,966) $ 40,511 $ 48,024
Loss from discontinued operations, net of income taxes (3,621) 11 1,040 (271) (9,711) (2,305) (15,946) (5,368) (235)
(Loss) income from continuing operations (6,346) 1,753 (7,776) 13,232 (5,826) 30,784 (3,020) 45,879 48,259
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                  
Depreciation and amortization 9,307 8,367 19,133 17,172 28,951 25,698 38,929 34,185 32,589
Provision for doubtful accounts 1,989 474 4,463 1,705 9,094 3,441 11,639 5,053 4,423
Impairment of long-lived assets and intangible assets         1,503   2,425    
Compensation expense on restricted stock units 2,356 2,093 5,152 4,599 7,138 7,004 9,642 9,346 8,213
Benefit from deferred income taxes 358   1,836 (2,564) 2,535 (2,564) (39,214) (14,499) (13,812)
Amortization of debt issuance costs 617 1,038 1,306 1,975 1,987 2,607 2,663 3,218 3,891
Loss on extinguishment of debt       6,645   6,645   6,645  
Gain on sale of property, plant and equipment (553) (277) (620) (900) (1,412) (6,369) (293) (6,258) (2,019)
Contingent consideration gains       (57) (49) (702) (85) (1,461) (1,388)
Changes in operating assets and liabilities, net of effects of acquired companies:                  
Net accounts receivable 9,521 9,332 (5,076) 747 (16,599) 791 (28,797) (8,855) (15,534)
Inventories (2,293) (1,449) (5,897) (2,258) (2,212) (3,740) 6,917 (3,493) 322
Other current assets and income taxes (3,966) (2,845) (8,560) (953) (21,566) 2,130 9,351 7,009 1,498
Accounts payable (4,335) (639) (2,971) 11,141 (751) 5,940 (777) 5,096 1,264
Accrued expenses, other current liabilities and accrued interest payable 2,117 3,990 1,172 (269) 25,499 3,158 40,186 687 3,451
Accrued compensation related costs (17,779) (23,186) (15,050) (18,900) (3,618) (9,952) (483) (6,566) 2,807
Other liabilities (144) 198 1,511 572 (750) 1,969 978 4,148 (169)
Net cash provided by operating activities - continuing operations (9,151) (1,151) (11,377) 31,887 23,924 66,840 50,061 80,134 73,795
Net cash used in operating activities - discontinued operations (1,479) 109 3,482 (2,227) (1,774) (2,261) (442) (3,102) (3,037)
Net cash provided by operating activities (10,630) (1,042) (7,895) 29,660 22,150 64,579 49,619 77,032 70,758
Cash flows from investing activities:                  
Purchase of property, plant and equipment, net of acquisitions (8,526) (3,450) (14,805) (13,741) (18,924) (19,174) (27,096) (25,907) (24,503)
Purchase of equipment leased to third parties under operating leases (564) (660) (1,663) (1,849) (2,609) (2,889) (4,012) (4,103) (2,763)
Acquisitions, net of cash acquired (19,142) (65) (33,934) (5,776) (36,784) (6,621) (38,097) (10,295) (61,401)
Change in restricted cash associated with workers' compensation program           3,120   3,120 (3,120)
Purchase of company-owned life insurance investment (2,294)   (2,294)   (2,294)   (2,294)   (2,000)
Proceeds from sale of property, plant and equipment 595 663 1,674 1,644 2,331 4,717 2,518 9,066 3,231
Net cash used in investing activities - continuing operations (29,931) (3,512) (51,022) (19,722) (58,280) (20,847) (68,981) (28,119) (90,556)
Net cash provided by (used in) investing activities - discontinued operations (265) (256) (464) (604) (532) (944) 2,507 (1,438) (1,118)
Net cash used in investing activities (30,196) (3,768) (51,486) (20,326) (58,812) (21,791) (66,474) (29,557) (91,674)
Cash flows from financing activities:                  
Borrowings under term loan       225,000   225,000   225,000  
Repayment of term loan (1,406) (750) (2,813) (293,300) (5,625) (294,706) (8,438) (296,113) (3,700)
Borrowings under revolving credit agreement 125,000 50,000 228,000 120,000 252,000 163,000 331,000 249,000  
Repayments under revolving credit agreement (38,000) (50,000) (163,000) (65,000) (203,000) (137,000) (286,000) (224,000)  
Payment of seller notes (1,631) (1,411) (3,569) (3,117) (6,845) (6,449) (9,435) (8,656) (4,904)
Payment of contingent consideration (375) (675) (626) (925) (700) (1,965) (825) (2,590) (2,915)
Payment of financing obligations (426) (324) (866) (658) (1,491) (997) (1,687) (1,367) (1,104)
Payment of fees associated with debt modifications and extinguishments       (3,665)   (3,665)   (3,665)  
Excess tax benefit from stock-based compensation 1,803 1,054 2,191 2,005 2,197 2,058 2,249 3,348 1,489
Proceeds from issuance of common stock 87 62 87 1,628 87 1,629 87 2,437 3,560
Purchase and retirement of common stock       (1,567)   (1,567)   (2,374) (1,350)
Net cash provided by (used in) financing activities - continuing operations 85,052 (2,044) 59,404 (19,599) 36,623 (54,662) 26,951 (58,980) (8,924)
Net cash used in financing activities - discontinued operations (3) (3) (6) (7) (9) (10) (10) (12) (353)
Net cash provided by (used in) financing activities 85,049 (2,047) 59,398 (19,606) 36,614 (54,672) 26,941 (58,992) (9,277)
Increase (decrease) in cash and cash equivalents 44,223 (6,857) 17 (10,272) (48) (11,884) 10,086 (11,517) (30,193)
Cash and cash equivalents, at beginning of year 1,613 13,130 1,613 13,130 1,613 13,130 1,613 13,130 43,323
Cash and cash equivalents, at end of year $ 45,836 $ 6,273 $ 1,630 $ 2,858 $ 1,565 $ 1,246 $ 11,699 $ 1,613 $ 13,130